Evidence mapPaperPMID 32954082Full record

ArticleKidney international reports2020

CKD Care and Research in Guatemala: Overview and Meeting Report.

Pablo Garcia, Carlos Mendoza, Joaquin Barnoya, Jose Monzón, Ann C Miller, Angie Aguilar-González, Julio Boj, Allan Cifuentes, Pedro Dávila, David Flood and 7 more

Abstract read
In one paragraph

Article in Kidney international reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Pablo GarciaStanford University School of Medicine, Palo Alto, California, USA.
Carlos MendozaInstitute of Nutrition of Central America and Panama (Instituto de Nutrición de Centroamérica y Panamá, INCAP), Guatemala.
Joaquin BarnoyaUnit for Cardiovascular Surgery (Unidad de Cirugía Cardiovascular de Guatemala, UNICAR), Guatemala.
Jose MonzónInstitute of Research and Higher Studies in Health Sciences (El Instituto de Investigación y Estudios Superiores en Ciencias de la Salud, IECIS), Rafael Landívar University, Guatemala.
Ann C MillerDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.
Angie Aguilar-GonzálezFoundation for Children with Kidney Disease (Fundación para el Niño Enfermo Renal, FUNDANIER), Guatemala.
Julio BojNational Center for Chronic Renal Disease (Unidad Nacional de Atención al Enfermo Renal Crónico, UNAERC), Guatemala.
Allan CifuentesGuatemalan Ministry of Health, Guatemala.
Pedro DávilaGuatemalan Nephrology Association (Asociación Guatemalteca de Nefrología, AGN), Guatemala.
David FloodCentro para Investigaciones sobre la Salud Indígena, Wuqu' Kawoq | Maya Health Alliance, Tecpán, Guatemala.
Carolina Guzmán-QuiloToxicology Department-SALTRA, Faculty of Chemical Sciences and Pharmacy, Universidad de San Carlos, Guatemala.
Agualuz HernandezGuatemalan Nephrology Association (Asociación Guatemalteca de Nefrología, AGN), Guatemala.
Randall Lou-MedaFoundation for Children with Kidney Disease (Fundación para el Niño Enfermo Renal, FUNDANIER), Guatemala.
Eduardo PalaciosChronic Diseases Program of the Ministry of Health of Guatemala, Guatemala.
Vicente Sánchez-PoloGuatemalan Institute of Social Security (Instituto Guatemalteco de Seguridad Social, IGSS), Guatemala.
Regina SosaGuatemalan Nephrology Association (Asociación Guatemalteca de Nefrología, AGN), Guatemala.
Peter RohloffCentro para Investigaciones sobre la Salud Indígena, Wuqu' Kawoq | Maya Health Alliance, Tecpán, Guatemala.

Funding

Pilot and Feasibility ProgramP30DK092926 · UNIVERSITY OF MICHIGAN AT ANN ARBOR · 2025 to 2025
$779k
FIC NIH HHS R21 TW010831NIDDK NIH HHS P30 DK092926
6 · The paper itself

Abstract

On October 14-15, 2019, the 1st Symposium to Promote Chronic Kidney Disease (CKD) Research in Guatemala was held in Guatemala City, Guatemala. The Symposium hosted more than 50 attendees, including health care professionals, policy makers, researchers, and leaders of nongovernmental organizations. The meeting's objectives were to (1) share clinical and health delivery experiences, (2) disseminate local research, and (3) establish consensus priorities for future research. In this report, we review the state of CKD nephrology in Guatemala, summarize experiences shared during the meeting from representatives of the clinical settings in Guatemala where CKD care is provided, and describe consensus priorities for future research.

Indexed as

end-stage kidney diseaseglobal healthglobal kidney careGuatemalaLatin Americameeting reportnephrology

Identifiers

PMID32954082
PMCPMC7486195

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.